Biotech Values

[palindromy]

I agree, the "bad placebo" has no case wrt DNDN. I was more curious actually then to see the science behind choice of placebo.

OTOH, Scher's letter certainly gives a lot of fodder for people in FDA to say that the general scientific community is not behind Provenge. That in any case was my impression from the very beginning. Add to the fact that DNDN couldnt even get their lead PI at the panel and I have not heard or seen anything to substantiate that Dr Small himself supports the approval of Provenge at this stage.